It’s not all about the ketones | Event Recording | VIA

Want to access this resource?

REGISTER NOW

OR LOGIN IF YOU ARE ALREADY REGISTERED

DESCRIPTION

Vitaflo sponsored symposium at the 7th Global Symposium on Medical Ketogenic Diet Therapies discussing the latest research for an alternative dietary management for drug resistant epilepsy. Professor Heales discusses some of the pre-clinical work for the mechanisms of decanoic acid (C10), providing an understanding to how the MCT diet works. This is followed by Professor Matthew Walker who discusses the clinical trial of K.Vita as an alternative dietary management for patients with drug resistant epilepsy (DRE).

You can read the K.Vita clinical paper on the Vitaflo UK site, please note this product will only be available in the UK in 2022.

Authors

Professor Simon Heales

UCL Chair of Clinical Chemistry, Head of Enzymes and Metabolic, Great Ormond Street Hospital and Neurometabolic Unit, National Hospital, London
Professor Matthew Walker

UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, London

Recorded

19/10/2021

TAGS

Drug Resistant Epilepsy - K.Vita

OTHER RESOURCES YOU MAY BE INTERESTED IN

K.Vita – From Laboratory To Clinical Use, Including Case Studies of Use In Glut 1 Deficiency Syndrome | Event Recording

K.Vita in an Unknown Epilepsy Syndrome | Event Recording

Using K.Vita in Tuberous Sclerosis Complex | Event Recording

Using K.Vita With a Tube-fed Patient With Drug Resistant Epilepsy | Event Recording

WE HAVE A WEALTH OF RESOURCES FOR

PKU - Infants

PKU - Children

PKU - Adolescents and Adults

Maternal PKU

PKU & GMP

Rare disorders of protein metabolism

Lipid Disorders

Glycogen Storage Disease

Drug Resistant Epilepsy - Ketogenic Diet

Drug Resistant Epilepsy - K.Vita

Paediatric Kidney Disease

Nutrition Support